Article citationsMore>>
Chu, H., Chan, J.F., Wang, Y., Yuen, T.T., Chai, Y., Hou, Y., Shuai, H., Yang, D., Hu, B., Huang, X., Zhang, X., et al. (2020) Comparative Replication and Immune Activation Profiles of SARS-CoV-2 and SARS-CoV in Human Lungs: An ex Vivo Study with Implications for the Pathogenesis of COVID-19. Clinical Infectious Diseases, 71, 1400-1409.
https://doi.org/10.1093/cid/ciaa410
has been cited by the following article:
-
TITLE:
SARS-COV-2 Induce Pulmonary Injury from Basic to Clinical Research
AUTHORS:
Jinguo Zhu
KEYWORDS:
COVID-19, SARS-CoV-2, Pulmonary Injury, Clinical Manifestation, Treatment Strategies
JOURNAL NAME:
World Journal of Cardiovascular Diseases,
Vol.12 No.3,
March
31,
2022
ABSTRACT: The SARS-CoV-2 has infected over 194,909,000 cases and over 4,170,000 deaths in the world before the end of July 2021. The virus attacks human alveoli and induces severe lung injury (COVID-19 disease) and spreads rapidly. The mechanisms of COVID-19 disease are unclear. To better understand this disease, This review analyzes the SARS-CoV-2 biological characteristics, insights the effect of alveolar epithelium and its adjacent microvascular endothelium, investigates human host cells immune response and immunothrombosis. Explains clinical manifestations of COVID-19 associated lung injury. It may be helpful for development management strategies for COVID-19 associated pulmonary damage.
Related Articles:
-
Ying Huang, Shuangyue Shao
-
Selcuk Yildirim
-
Adetola Olaide Adesanya, Mattew Remilekun Odekunle, Mfon Odo Udoh
-
Rick W. Rorie, Pedro A. Delgado, Toby D. Lester
-
Jacques Touma